ESC Premium Access

The role of modifiable risk factors for the maintenance of sinus rhythm in the atrial fibrillation patient.

Congress Presentation

About the speaker

Professor Jonathan Kalman

Royal Melbourne Hospital, Melbourne (Australia)
8 presentations
0 follower

3 more presentations in this session

When is ablation the preferred approach to treat atrial fibrillation?

Speaker: Professor D. Gupta (Liverpool, GB)

Thumbnail

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

Speaker: Professor I. Deisenhofer (Munich, DE)

Thumbnail

Choosing wisely: ablation or medication for rhythm control in atrial fibrillation – discussion.

Thumbnail

Access the full session

Choosing wisely: ablation or medication for rhythm control in atrial fibrillation?

Speakers: Professor J. Kalman, Professor D. Gupta, Professor I. Deisenhofer
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

EHRA Premium Access

Physiological pacing.

3 April 2022

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

ESC Premium Access

Acute safety and performance outcomes from the inspIRE trial using a novel pulsed field ablation system for the treatment of paroxysmal atrial fibrillation

27 August 2021

ESC 365 is supported by

logo Novo Nordisk